Stay up to date with the latest Adelaide University news.
Featured news
12 May 2026
Algal bloom crisis shows climate risks need evaluative governance
Identifying and analysing climate risks is a necessary function of governments, but researchers at Adelaide University’s Environment Institute argue such processes will not lead to effective action without taking additional steps to understand which risks are considered unacceptable by the community and prioritising responses accordingly. “Australia is getting better at identifying climate risks, b...
Twisted light breakthrough could enable earlier disease detection
Researchers from the Australian Research Council Centre of Excellence in Optical Microcombs for Breakthrough Science (COMBS) have developed a powerful new way to use light to measure tiny changes in biological fluids such as blood – using samples as small as a millionth of a drop. The breakthrough, led by teams at Adelaide University, RMIT University and the University of St Andrews (UK), could ena...
UPDATED: Global incident impacting Canvas learning management system
We are pleased to advise the Adelaide University community that Canvas access has been restored, and teaching and learning can resume. We understand how disruptive this global cyber security incident has been for staff and students, particularly during assessment periods, and we thank our community for their understanding. The safety of our community has been our number one priority as we have cont...
Complex habitat crucial to brush-tailed rock-wallaby survival
New research shows terrain complexity is an important factor when brush-tailed rock-wallabies choose habitat, providing critical insight to help bring the critically endangered species back from the brink. Brush-tailed rock-wallaby populations have dwindled for more than a century due to historical hunting for the European fur trade and competition and predation from introduced species.
Type 2 diabetes affects millions of people worldwide and now a new international study, jointly led by Adelaide University, University of Oxford, ETH Zurich, and Stanford University, has found one in ten people may not be benefiting from common medications used to treat the condition. The collaborative study discovered genetic variations present in ten per cent of the population could prevent GLP-1...